相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety and Tolerability of Luliconazole Solution 10-Percent in Patients with Moderate to Severe Distal Subungual Onychomycosis
T. Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Epidemiology, Etiology, and Pathophysiology of Onychomycosis
Richard K. Scher et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2013)
Short-Term Therapy with Luliconazole, a Novel Topical Antifungal Imidazole, in Guinea Pig Models of Tinea Corporis and Tinea Pedis
Hiroyasu Koga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Ungual and Transungual drug delivery
H. N. Shivakumar et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2012)
New therapeutic options for onychomycosis
Aditya K. Gupta et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study
HR Jerajani et al.
INDIAN JOURNAL OF DERMATOLOGY (2012)
Toenail onychomycosis: an important global disease burden
J. Thomas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model
M. A. Ghannoum et al.
MEDICAL MYCOLOGY (2010)
In vitro antifungal activities of luliconazole, a new topical imidazole
Hiroyasu Koga et al.
MEDICAL MYCOLOGY (2009)
Anti-infectives - Recent progress on the topical therapy of onychomycosis
Michael R. K. Alley et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis - comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study
Shinichi Watanabe et al.
MYCOSES (2007)
A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis
S Watanabe et al.
MYCOSES (2006)
Intracutaneous distributions of fluconazole, itraconazole, and griseofulvin in guinea pigs and binding to human stratum corneum
S Sobue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species
K Uchida et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis
K Uchida et al.
MICROBIOLOGY AND IMMUNOLOGY (2003)
A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns
MA Ghannoum et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)